With this research the investigators hope to determine the lowest dose of ropivacaine used in
transversus abdominis plane (TAP) blocks that can effectively treat pain in women after
cesarean section (c-section).
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02893423
Ages eligible for Study
Genders eligible for Study
Accepts Healthy Volunteers
Pregnant patients undergoing elective c-section
Allergy to local anesthetics
Contraindication to tap blocks
All locations for NCT02893423
United States (1)
Maimonides Medical Center
Brooklyn, New York, United States, 11219
View full eligibility
Tris trial is registered with FDA with number: NCT02893423. The sponsor of the trial is Maimonides Medical Center and it is looking for 51 volunteers for the current phase.
Official trial title: The Dose Dependent Effect of Ropivacaine Transversus Abdominis Plane Blocks on Postoperative Analgesia After Cesarean Section
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.